Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

5.95
Delayed Data
As of 3:59pm ET
 +0.2715 / +4.78%
Today’s Change
3.71
Today|||52-Week Range
10.20
+30.48%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$65.6M

Company Description

Oramed Pharmaceuticals, Inc. engages in the research and development of oral pharmaceutical products. It offers oral insulin capsules for diabetes. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.

Contact Information

Oramed Pharmaceuticals, Inc.
Hi-Tech Park 2/4
Jerusalem Jerusalem 91390
P:(722) 566-0001
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Nadav KidronPresident, Chief Executive Officer & Director
Joshua HexterChief Operating Officer & VP-Business Development
Yifat ZommerChief Financial Officer, Secretary & Treasurer
Miriam KidronDirector & Chief Scientific Officer